These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 20957484)

  • 1. Impact of troponin I-autoantibodies in chronic dilated and ischemic cardiomyopathy.
    Doesch AO; Mueller S; Nelles M; Konstandin M; Celik S; Frankenstein L; Goeser S; Kaya Z; Koch A; Zugck C; Katus HA
    Basic Res Cardiol; 2011 Jan; 106(1):25-35. PubMed ID: 20957484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of protein A immunoadsorption in patients with advanced chronic dilated cardiomyopathy.
    Doesch AO; Konstandin M; Celik S; Kristen A; Frankenstein L; Hardt S; Goeser S; Kaya Z; Katus HA; Dengler TJ
    J Clin Apher; 2009; 24(4):141-9. PubMed ID: 19591221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of auto-antibodies against cardiac troponin I predicts improvement of left ventricular function after acute myocardial infarction.
    Leuschner F; Li J; Göser S; Reinhardt L; Ottl R; Bride P; Zehelein J; Pfitzer G; Remppis A; Giannitsis E; Katus HA; Kaya Z
    Eur Heart J; 2008 Aug; 29(16):1949-55. PubMed ID: 18556712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of troponin I efflux and troponin autoantibodies in patients with dilated cardiomyopathy.
    Miettinen KH; Eriksson S; Magga J; Tuomainen P; Kuusisto J; Vanninen EJ; Turpeinen A; Punnonen KR; Pettersson K; Peuhkurinen KJ
    J Card Fail; 2008 Aug; 14(6):481-8. PubMed ID: 18672196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies to cardiac troponin I in patients with idiopathic dilated and ischemic cardiomyopathy.
    Shmilovich H; Danon A; Binah O; Roth A; Chen G; Wexler D; Keren G; George J
    Int J Cardiol; 2007 Apr; 117(2):198-203. PubMed ID: 16887211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential role of antibodies against cardiac Kv channel-interacting protein 2 in dilated cardiomyopathy.
    Landsberger M; Staudt A; Choudhury S; Trimpert C; Herda LR; Klingel K; Kandolf R; Schultheiss HP; Kroemer HK; Völker U; Felix SB
    Am Heart J; 2008 Jul; 156(1):92-99.e2. PubMed ID: 18585502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term benefits of immunoadsorption in β(1)-adrenoceptor autoantibody-positive transplant candidates with dilated cardiomyopathy.
    Dandel M; Wallukat G; Englert A; Lehmkuhl HB; Knosalla C; Hetzer R
    Eur J Heart Fail; 2012 Dec; 14(12):1374-88. PubMed ID: 22892122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulating autoantibodies directed against the cardiac beta1-adrenergic receptor predict increased mortality in idiopathic cardiomyopathy.
    Störk S; Boivin V; Horf R; Hein L; Lohse MJ; Angermann CE; Jahns R
    Am Heart J; 2006 Oct; 152(4):697-704. PubMed ID: 16996841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantigen estimation and simple screening assay against cardiodepressant autoantibodies in patients with dilated cardiomyopathy.
    Baba A
    Ther Apher Dial; 2008 Apr; 12(2):109-16. PubMed ID: 18387158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of dyslipidaemia in patients with heart failure of unexplained aetiology.
    Skwarek M; Bilińska ZT; Mazurkiewicz Ł; Grzybowski J; Kruk M; Kurjata P; Piotrowski W; Ruzyłło W
    Kardiol Pol; 2008 May; 66(5):515-22, discussion 523-4. PubMed ID: 18537059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoadsorption can improve cardiac function in transplant candidates with non-ischemic dilated cardiomyopathy associated with diabetes mellitus.
    Dandel M; Englert A; Wallukat G; Riese A; Knosalla C; Stein J; Hetzer R
    Atheroscler Suppl; 2015 May; 18():124-33. PubMed ID: 25936316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional heterogeneity of decreased myocardial norepinephrine and increased lipid peroxidation levels in patients with end-stage failing heart secondary to dilated or ischemic cardiomyopathy.
    Rochette L; Tatou E; Vergely C; Maupoil V; Bouchot O; Mossiat C; Jazayeri S; Benkhadra S; Brenot R; Girard C; David M
    J Heart Lung Transplant; 2008 Jul; 27(7):767-74. PubMed ID: 18582807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective familial assessment in dilated cardiomyopathy: cardiac autoantibodies predict disease development in asymptomatic relatives.
    Caforio AL; Mahon NG; Baig MK; Tona F; Murphy RT; Elliott PM; McKenna WJ
    Circulation; 2007 Jan; 115(1):76-83. PubMed ID: 17179019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of heart transplantation patients with ischemic and idiopathic dilated cardiomyopathy.
    Gungor H; Oguz E; Ayik MF; Ertugay S; Engin C; Yagdi T; Nalbantgil S; Zoghi M; Ozbaran M
    Transplant Proc; 2011 Dec; 43(10):3847-50. PubMed ID: 22172858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and prognostic value of Duke's Activity Status Index along with plasma B-type natriuretic peptide levels in chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Parissis JT; Nikolaou M; Birmpa D; Farmakis D; Paraskevaidis I; Bistola V; Katsoulas T; Filippatos G; Kremastinos DT
    Am J Cardiol; 2009 Jan; 103(1):73-5. PubMed ID: 19101233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy.
    Caforio AL; Tona F; Bottaro S; Vinci A; Dequal G; Daliento L; Thiene G; Iliceto S
    Autoimmunity; 2008 Feb; 41(1):35-45. PubMed ID: 18176863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevalence of sleep-related breathing disorders in ischemic and non-ischemic heart failure].
    Oldenburg O; Lamp B; Töpfer V; Faber L; Teschler H; Horstkotte D
    Dtsch Med Wochenschr; 2007 Mar; 132(13):661-6. PubMed ID: 17377879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy.
    Fu LX; Magnusson Y; Bergh CH; Liljeqvist JA; Waagstein F; Hjalmarson A; Hoebeke J
    J Clin Invest; 1993 May; 91(5):1964-8. PubMed ID: 7683693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of bridge-to-transplant ventricular assist device support on survival after cardiac transplantation.
    Bull DA; Reid BB; Selzman CH; Mesley R; Drakos S; Clayson S; Stoddard G; Gilbert E; Stehlik J; Bader F; Kfoury A; Budge D; Eckels DD; Fuller A; Renlund D; Patel AN
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):169-73. PubMed ID: 20451930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The predictive values of beta1-adrenergic and M2 muscarinic receptor autoantibodies for sudden cardiac death in patients with chronic heart failure.
    Pei J; Li N; Chen J; Li X; Zhang Y; Wang Z; Zhang P; Cao K; Pu J
    Eur J Heart Fail; 2012 Aug; 14(8):887-94. PubMed ID: 22713286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.